LY03017

· Luye Pharma Group Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LY03017, covering 2024-04-29 to 2025-05-20. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017 [Phase 1]